DrugPatentWatch Database Preview
Patent: 10,376,658
» See Plans and Pricing
Summary for Patent: 10,376,658
| Title: | Device for cell spraying |
| Abstract: | The invention provides a description of a method and a device suitable for producing a cell suspension spray with living cells, and the produced cell preparation, suitable for grafting to a patient. In contrast to other methods, the spraying is performed through a disposable needle which is inserted into a disposable air tube; which provides a cell distribution avoiding spray nozzles. Small suspension droplets are provided instead of cell nebulization. By using medical grade sterile Luer-lock disposables from medical routine praxis, biocompatibility and easy application is addressed. In applying the method and/or in using the device, cells suitable for grafting to a patient are dispersed in a solution and sprayed with the device for distribution over the recipient graft site. |
| Inventor(s): | Bornemann; Reinhard (Bielefeld, DE) |
| Assignee: | RenovaCare Sciences Corp. (New York, NY) |
| Application Number: | 15/360,230 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,376,658
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith And Nephew | SANTYL | collagenase | OINTMENT;TOPICAL | 101995 | 001 | 1965-06-04 | Start Trial | RenovaCare Sciences Corp. (New York, NY) | 2032-08-13 | RX | search | |
| Akorn Inc | HYDASE | hyaluronidase | INJECTABLE;INJECTION | 021716 | 001 | 2005-10-25 | Start Trial | RenovaCare Sciences Corp. (New York, NY) | 2032-08-13 | DISCN | search | |
| Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | Start Trial | RenovaCare Sciences Corp. (New York, NY) | 2032-08-13 | RX | search | |
| Bausch And Lomb | VITRASE | hyaluronidase | INJECTABLE;INJECTION | 021640 | 002 | 2004-12-21 | Start Trial | RenovaCare Sciences Corp. (New York, NY) | 2032-08-13 | RX | search | |
| Bausch And Lomb | VITRASE | hyaluronidase | INJECTABLE;INJECTION | 021640 | 001 | 2004-12-21 | Start Trial | RenovaCare Sciences Corp. (New York, NY) | 2032-08-13 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,376,658
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| United States of America | 2013060335 | Start Trial |
| United States of America | 2017196679 | Start Trial |
| United States of America | 2020061311 | Start Trial |
| United States of America | 9505000 | Start Trial |
| Germany | 102011100450 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
